Literature DB >> 18030564

Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer.

Shu-Hai Li1, Zhou Wang, Xiang-Yan Liu, Fan-Ying Liu, Zhao-Yi Sun, Han Xue.   

Abstract

PURPOSE: To investigate the prevalence of lymph node micrometastasis (LNMM) on the basis of the detection of MUC1 mRNA, and assess the impact of these micrometastases on disease-free interval after resection of pathologic N0 (pN0) esophageal squamous cell cancer (ESCC).
METHODS: The subjects were 93 patients who underwent complete resection of pN0 ESCC at our department between January 1999 and January 2001. All lymph nodes (426 stations) obtained from these patients were reevaluated by reverse transcription-polymerase chain reaction to detect MUC1 mRNA. The diagnosis of LNMM was based on the detection of MUC1 mRNA. A log-rank test was performed to compare the disease-free interval, and Cox regression multivariate analysis was performed to determine the independent prognostic factors.
RESULTS: Micrometastasis was detected in 40 lymph node stations (9.4%) from 32 patients (34.4%). Disease-free interval was significantly associated with LNMM (P = 0.0138). The 5-year survival rate of patients with LNMM was significantly lower than that of those without LNMM (P = 0.004). The results of multivariate analysis confirmed that T status and LNMM were independent prognostic factors.
CONCLUSIONS: The prevalence of LNMM in patients with pN0 ESCC was 34.4% (32/93). Thus, LNMM was significantly associated with the disease-free interval. T status and LNMM were both independent prognostic factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18030564     DOI: 10.1007/s00595-007-3548-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  N1 esophageal carcinoma: the importance of staging and downstaging.

Authors:  T W Rice; E H Blackstone; D J Adelstein; G Zuccaro; J J Vargo; J R Goldblum; L A Rybicki; S C Murthy; M M Decamp
Journal:  J Thorac Cardiovasc Surg       Date:  2001-03       Impact factor: 5.209

2.  Malignant potential and cytogenetic characteristics of occult disseminated tumor cells in esophageal cancer.

Authors:  S Hosch; J Kraus; P Scheunemann; J R Izbicki; C Schneider; U Schumacher; K Witter; M R Speicher; K Pantel
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

3.  Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer.

Authors:  Siva Raja; James D Luketich; Lori A Kelly; William E Gooding; Sydney D Finkelstein; Tony E Godfrey
Journal:  J Thorac Cardiovasc Surg       Date:  2002-03       Impact factor: 5.209

4.  The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.

Authors:  J N Glickman; C Torres; H H Wang; J R Turner; A Shahsafaei; W G Richards; D J Sugarbaker; R D Odze
Journal:  Cancer       Date:  1999-02-15       Impact factor: 6.860

5.  Proposed revision of the staging classification for esophageal cancer.

Authors:  R J Korst; V W Rusch; E Venkatraman; M S Bains; M E Burt; R J Downey; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  1998-03       Impact factor: 5.209

6.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

7.  [Gene diagnosis and prognosis of mediastinal lymph node occult micrometastasis in non-small cell lung carcinoma].

Authors:  Zhou Wang; Hongnian Yin; Lin Zhang; Xingang Lan; Houwen Li
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2002-05

Review 8.  Clinical significance of micrometastasis in lung and esophageal cancer: a new paradigm in thoracic oncology.

Authors:  Xiaolong Jiao; Mark J Krasna
Journal:  Ann Thorac Surg       Date:  2002-07       Impact factor: 4.330

9.  Expression of MUC1 in esophageal squamous-cell carcinoma and its relationship with prognosis of patients from Linzhou city, a high incidence area of northern China.

Authors:  Zi-Bo Song; Shan-Shan Gao; Xin-Na Yi; Yan-Jie Li; Qi-Ming Wang; Ze-Hao Zhuang; Li-Dong Wang
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

10.  Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptase-polymerase chain reaction.

Authors:  C T Salerno; S Frizelle; G A Niehans; S B Ho; M Jakkula; R A Kratzke; M A Maddaus
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

View more
  12 in total

1.  Impact of perioperative peripheral blood values on postoperative complications after esophageal surgery.

Authors:  Hiroshi Saeki; Takanobu Masuda; Satoko Okada; Koji Ando; Masahiko Sugiyama; Keiji Yoshinaga; Kazuya Endo; Noriaki Sadanaga; Yasunori Emi; Yoshihiro Kakeji; Masaru Morita; Natsumi Yamashita; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

2.  Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy.

Authors:  Zhi-Gang Sun; Zhou Wang; Xiang-Yan Liu; Fan-Ying Liu
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

3.  A suspected [18F]fluorodeoxyglucose positron emission tomography-negative metastatic lymph node successfully diagnosed by laparoscopic staging in esophageal cancer: report of two cases.

Authors:  Atsushi Takeno; Shuji Takiguchi; Makoto Yamasaki; Hiroshi Miyata; Ryohei Kawabata; Yoichiro Nushijima; Tomoki Makino; Yoshiyuki Fujiwara; Kiyokazu Nakajima; Toshiro Nishida; Masaki Mori; Yuichiro Doki
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

4.  USP22 nuclear expression is significantly associated with progression and unfavorable clinical outcome in human esophageal squamous cell carcinoma.

Authors:  Jun Li; Zhou Wang; Yu Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-25       Impact factor: 4.553

5.  Micrometastasis of hypopharyngeal cancer.

Authors:  P Sabljak; P Pesko; D Stojakov; M Micev; E Keramatollah; D Velickovic; O Skrobic; V Sljukic; A Djikic-Rom
Journal:  Langenbecks Arch Surg       Date:  2014-05-11       Impact factor: 3.445

6.  Metastasis-associated protein 1 (MTA1) overexpression is closely associated with shorter disease-free interval after complete resection of histologically node-negative esophageal cancer.

Authors:  Shu-Hai Li; Zhou Wang; Xiang-Yan Liu
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

Review 7.  Lymph node micrometastasis in gastrointestinal tract cancer--a clinical aspect.

Authors:  Shoji Natsugoe; Takaaki Arigami; Yoshikazu Uenosono; Shigehiro Yanagita; Akihiro Nakajo; Masataka Matsumoto; Hiroshi Okumura; Yuko Kijima; Masahiko Sakoda; Yuko Mataki; Yasuto Uchikado; Shinichiro Mori; Kosei Maemura; Sumiya Ishigami
Journal:  Int J Clin Oncol       Date:  2013-06-18       Impact factor: 3.402

Review 8.  Sentinel node navigation surgery in esophageal cancer.

Authors:  Hiroya Takeuchi; Yuko Kitagawa
Journal:  Ann Gastroenterol Surg       Date:  2018-09-05

9.  Clinical study on postoperative recurrence in patients with pN0 esophageal squamous cell carcinoma.

Authors:  Xu-Feng Guo; Teng Mao; Zhi-Tao Gu; Chun-Yu Ji; Wen-Tao Fang; Wen-Hu Chen
Journal:  J Cardiothorac Surg       Date:  2014-08-28       Impact factor: 1.637

10.  The presence of lymphovascular and perineural infiltration after neoadjuvant therapy and oesophagectomy identifies patients at high risk for recurrence.

Authors:  S M Lagarde; A W Phillips; M Navidi; B Disep; A Immanuel; S M Griffin
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.